[1] 韩莹, 丁惠国. 抗病毒治疗乙型肝炎肝硬化的过去、现在和将来. 实用肝脏病杂志,2015,18(5):453-456. [2] Nawaz A,Nazar H,Usmanghani K,et al.Ways to manage hepatitis C without cirrhosis:Treatment by comparison of coded eastern medicine hepcinal with interferon alpha 2b and ribavirin. Pak J Pharmaceut Sci,2016,29(3):919. [3] Lenz K,Buder R,Kapun L,et al.Treatment and management of ascites and hepatorenal syndrome:an update. Therap Adv Gastroenterol,2015,8(2):83. [4] Low G,Owen N E,Joubert I,et al.Magnetic resonance elastography in the detection of hepatorenal syndrome in patients with cirrhosis and ascites. Eur Radiol,2015,25(10):2851-2858. [5] Boyer T D,Sanyal A J,Pappas S C,et al.P0198:Percentage change in serum creatinine(sCr) is a sensitive indicator of therapeutic response to terlipressin in hepatorenal syndrome type 1 (HRS-1). J Hepatol,2015,62(12):379-380. [6] 陈洪,张宝和,李洪艳,等. 大鼠模拟高强度军事训练肾损伤后肾组织肾损伤分子-1、中性粒细胞明胶酶相关脂质运载蛋白的变化及其意义. 中国运动医学杂志,2015,34(8):770-774.、 [7] 闫芳,张会军,苏振宇,等. 血清中NGAL水平在法洛四联症患儿术后急性肾功能损伤中意义的研究. 中国胸心血管外科临床杂志,2016,23(6):613-616. [8] 中华医学会肝病学分会和感染病学分会.慢性乙型肝炎防治指南(2015年版).实用肝脏病杂志,2016,19(3):Ⅴ-ⅩⅩⅢ. [9] Seetlani N K,Memon A R,Iftikhar F,et al.Hepatorenal syndrome in patients with cirrhosis of liver according to 2007 international ascites club criteria. J Ayub Med Coll Abbottabad,2016,28(3):578-581. [10] 刘景峰,田领,白江涛,等. 乙型肝炎肝硬化并发原发性肝癌患者感染的临床特征. 中华医院感染学杂志,2016,26(14):3176-3178. [11] 汤雯,贾继东,Tang Wen,等. 肝硬化患者门静脉血栓形成的发病机制及诊断进展. 中华肝脏病杂志,2015,23(7):550-552. [12] Scaglione S,Kliethermes S,Cao G,et al.The epidemiology of cirrhosis in the united states:apopulation-based study. J Clin Gastroenterol,2015,49(8):690-696. [13] 田秋菊,贾继东. 肝硬化腹水及其相关并发症治疗新进展. 实用肝脏病杂志,2015,18(1):1-3. [14] 谢玉兰,勾春燕,李丽,等. 健脾活血利水方治疗肝硬化腹水的临床观察. 中国中医急症,2015,24(12):2233-2235. [15] Blomeyer S,Tyczynski B,Gerken G,et al.Diagnosis and therapy of the hepatorenal syndrome. Deut Medizin Wochensch,2015,140(14):1091-1092. [16] Yap D Y,Seto W K,Fung J,et al.Serum and urinary biomarkers that predict hepatorenal syndrome in patients with advanced cirrhosis. Dig Liver Dis,2016,24(11):638-643. [17] Wang P,Huang J,Li Y,et al.Exogenous carbon monoxide decreases sepsis-induced acute kidney injury and inhibits NLRP3 inflammasome activation in rats. Int J Mol Sci,2015,16(9):20595-20608. [18] 张关亭. CysC、β2微球蛋白、肌酐、尿素氮在2型糖尿病肾病不同阶段的水平变化及诊断价值. 中华全科医学,2017,15(5):850-852. [19] Kumar D,Singla S K,Puri V,et al.The restrained expression of NF-kB in renal tissue ameliorates folic acid induced acute kidney injury in mice. Plos One,2015,10(1):5947. [20] 李平华,宋倩,黄连铭. 血清肌酐、胱抑素C、NGAL检测对妊娠相关急性肾损伤诊断及预后评估的价值. 中国计划生育学杂志,2017,25(5):308-313. [21] Benzer M,Alpay H,Baykan, et al. Serum NGAL,cystatin C and urinary NAG measurements for early diagnosis of contrast-induced nephropathy in children. Renal Fail,2015,38(1):1. [22] Stelmach-Goldys A,Czarkowska-Paczek B,Paczek L.Serum cystatin C and serum and urine NGAL in the kidney function assessment of patients with MGUS. Eur J Haematol,2015,94(2):162-168. [23] 张忠臣,吴丽丽,陈霞,等. 人中性粒细胞明胶酶相关脂质运载蛋白与2型肝肾综合征患者预后的关系. 中华肝脏病杂志,2015,23(6):449-453. [24] Karaolanis G,Katsaros A,Palla V V,et al.Urine NGAL as a biomarker of kidney damage after on- and off-pump coronary artery bypass graft surgery:aprospective pilot study. Hellen J Cardiol,2015,56(2):160-168. [25] Leelahavanichkul A,Somparn P,Issaraamphorn J,et al.Serum neutrophil gelatinase associated lipocalin(NGAL) outperforms serum creatinine in detecting sepsis-induced acute kidney injury,experiments on bilateral nephrectomy and bilateral ureter obstruction mouse models. Shock,2016,45(5):570. |